type 1 diabetes and glp 1 Scripts for GLP-1, SGLT2 Drugs on the Rise in Patients Glucagon-like peptide-1 receptor agonists and

Added effect-size detail from cited studies

Med Oncol 29(4):27182726 Welford AF et al (2011) TIE2-expressing macrophages limit the therapeutic efficacy of the vascular-disrupting agent combretastatin A4 phosphate in mice

This drug, which was originally used as a glycemic control medication for diabetes, has recently been approved for weight loss by the FDA

The most significant activation of the enzymatic antioxidant system was detected in mushrooms stored using modified atmosphere packaging combined with vacuum cooling treatment

Data mining, data normalisation, and data analysis AMDIS software was employed to deconvolute GC-MS chromatograms and identify metabolites using our in-house MCF mass spectra library

Biochem Biophys Res Commun 396(4):901907 Marseglia L, Manti S, DAngelo G, Nicotera A, Parisi E, Rosa Di, Gitto E, Arrigo T (2015) Oxidative stress in obesity: a critical component in human diseases